4th Quarter - Report

CAPITOL COUNSEL LLC for ASTRAZENECA PHARMACEUTICALS, LP

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care reform; drug safety, pricing and reimbursement; comparative effectiveness; proposed revisions to 340B program, including implementation of related provisions in comprehensive health care reform: P.L. 111-148, Patient Protection and Affordable Care Act and P.L. 111-152, Health Care and Education Reconciliation Act and revisions in HR 4994 Medicare & Medicaid Extender Act.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4994 (111th)

Medicare/Medicaid MMM

Medicare and Medicaid coverage, coding and reimbursement of pharmaceuticals; Medicare Part D coverage gap and discount program, rebates for Medicare and Medicaid dual-eligibles, including implementation of related provisions in comprehensive health care reform: P.L. 111-148, Patient Protection and Affordable Care Act and P.L. 111-152, Health Care and Education Reconciliation Act

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.